Stelios Papadopoulos's Net Worth
Stelios Papadopoulos's net worth is estimated to be at least $17,123,486.37 as of 06/27/2025. CoreStreet's estimation of Stelios Papadopoulos's net worth is based on their sale of stock and current holding of stock.
Stelios Papadopoulos is Director at Exelixis Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 36,508 units of EXEL stock on 05/15/2025. Their biggest sale was on 09/19/2017 when they sold 200,000 units of Exelixis Inc stock for $5,536,000.00. They typically trade 1 times per year.
Total value of insider buys:
- $3,826,208.97
Total value of insider sells:
- $13,297,277.40
Most recent insider trade:
- May 15, 2025
Stelios Papadopoulos's Insider Trading History
| Exelixis Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 15, 2025 | Director | 36,508 | $44.35 | Sell | $1,619,129.80 |
Feb. 22, 2022 | Director | 84,515 | $19.56 | Sell | $1,653,113.40 |
May 11, 2021 | Director | 20,770 | $24.98 | Sell | $518,834.60 |
May 8, 2020 | Director | 45,000 | $25.84 | Sell | $1,162,800.00 |
May 7, 2018 | Director | 15,000 | $22.15 | Sell | $332,250.00 |
Sept. 22, 2017 | Director | 10,000 | $25.40 | Sell | $254,000.00 |
Sept. 19, 2017 | Director | 200,000 | $27.68 | Sell | $5,536,000.00 |
Sept. 18, 2017 | Director | 72,210 | $27.76 | Sell | $2,004,549.60 |
March 20, 2017 | Director | 10,000 | $21.66 | Sell | $216,600.00 |
| Regulus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 28, 2018 | Director | 50,000 | $1.09 | Buy | $54,500.00 |
Dec. 27, 2018 | Director | 116,401 | $0.97 | Buy | $112,908.97 |
March 22, 2017 | Director | 500,000 | $1.22 | Buy | $610,000.00 |
| Biogen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 27, 2015 | Director | 10,000 | $304.88 | Buy | $3,048,800.00 |